Controlled Study of ONO-5046Na in Patients With Acute Respiratory Failure Associated With Community-Acquired Pneumonia

PHASE2CompletedINTERVENTIONAL
Enrollment

174

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

August 31, 2009

Conditions
Community-acquired Pneumonia
Interventions
DRUG

ONO-5046Na

twenty four hour infusion at 0 mg/kg/hr for 14 days

DRUG

ONO-5046Na

twenty four hour intravenous infusion at 0.2 mg/kg/hr for 14 days

Trial Locations (9)

Unknown

Chugoku Region, Chugoku

Chubu Region, Chūbu

Hokkaido Region, Hokkaido

Hokuriku Region, Hokuriku

Kanto Region, Kanto

Kinki Region, Kinki

Kyushu Region, Kyushu

Shikoku Region, Shikoku

Tohoku Region, Tohuku

Sponsors
All Listed Sponsors
lead

Ono Pharmaceutical Co. Ltd

INDUSTRY

NCT00417326 - Controlled Study of ONO-5046Na in Patients With Acute Respiratory Failure Associated With Community-Acquired Pneumonia | Biotech Hunter | Biotech Hunter